HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Methylparaben Accumulation Noted In UK Breast Tumor Study

This article was originally published in The Rose Sheet

Executive Summary

Additional research, including studies measuring the levels of parabens in healthy breast tissue, is needed to evaluate the possible connection between the cosmetics preservatives and breast cancer, according to a British study published in the January issue of the Journal of Applied Toxicology

You may also be interested in...



British Report Questions Link Between Antiperspirant Use And Cancer

Further research should be conducted to determine the role of aluminum in the development of human breast cancer, according to a British report published in the May/June issue of the Journal of Applied Toxicology

British Report Questions Link Between Antiperspirant Use And Cancer

Further research should be conducted to determine the role of aluminum in the development of human breast cancer, according to a British report published in the May/June issue of the Journal of Applied Toxicology

“Ideal” Preservatives Must Use Multifunctional Additives – Kinetik Exec

Formulating cosmetic preservatives with multifunctional additives featuring antimicrobial properties will allow manufacturers to reduce their dependence on traditional preservatives like parabens, according to Kinetik Technologies Director of Technical Sales and Marketing Christopher Johnson

Related Content

Latest News
See All
UsernamePublicRestriction

Register

RS011828

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel